Form D · Pharmaceuticals
Pennino Corp
New York, NY · CIK 0001462771
Offering snapshot reported Jun 8, 2009 · SEC filing
- Reported sold
- $10K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 21, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 8, 2009 | Initial | $10,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-131774
Source: Form D, filed Jun 8, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joe Pennino | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
39 W 75 Th Street, Suite F
New York, NY, 10023
New York, NY, 10023